Heidelberg Spectralis OCT

DEVICE2 trials

Sponsors

Heidelberg Engineering GmbH, Memorial Sloan Kettering Cancer Center

Conditions

GlaucomaOcular Tumor

Unknown Phase

Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)

TerminatedNCT02785042

Heidelberg Engineering GmbHGlaucoma

Start: 2016-06-30End: 2023-07-31Updated: 2025-03-19

A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors

RecruitingNCT07449195

Memorial Sloan Kettering Cancer CenterOcular Tumor

Start: 2026-02-27End: 2028-02-27Target: 60Updated: 2026-05-13